Moscow, Russia

Arkady Vasilievich Nekrasov


Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Arkady Vasilievich Nekrasov: Innovator in Pharmacological Compounds

Introduction

Arkady Vasilievich Nekrasov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmacology, particularly in the development of innovative compounds with therapeutic applications. With a total of 2 patents, his work focuses on enhancing drug safety and efficacy.

Latest Patents

Nekrasov's latest patents include "Heterochain aliphatic poly-N-oxide copolymers and vaccinating agents and drugs based thereon." This invention presents a new class of compounds that exhibit a wide range of pharmacological activity, including antioxidant effects and therapeutic benefits as a detoxicant and immunomodulating agent. The copolymer can be utilized as a vaccinating agent, which may include an antigen and a vaccine against hepatitis A and hepatitis B. His second patent, "Compounds for the prevention and treatment of helminth infections," describes a compound that protects vertebrates against helminth infections. This compound comprises hyaluronidase covalently coupled to an immunostimulating carrier, specifically a copolymer of ethylenepiperazine N-oxide and N-ethylacetylethylenepiperazinium bromide, known as SYNPOL.

Career Highlights

Throughout his career, Nekrasov has worked with various companies, including Petrovax LLC and NPO Petrovaks Farm. His innovative research has contributed to advancements in drug development and safety.

Collaborations

Nekrasov has collaborated with notable individuals in his field, including Emma K Daugalieva and Rem V Petrov. These partnerships have furthered his research and development efforts.

Conclusion

Arkady Vasilievich Nekrasov is a distinguished inventor whose work in pharmacological compounds has the potential to significantly impact medical treatments. His innovative patents reflect a commitment to improving drug safety and efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…